痤瘡治療市場：按藥物類別、類型、適應症、配方、分銷渠道、地區 - 規模、份額、展望、機會分析，2022-2030 年

痤瘡是一種皮膚病，當髮根被皮脂和死皮細胞堵塞時就會發生。 結果是粉刺、黑頭和白頭。 儘管任何年齡的人都可能患上它，但痤瘡在青少年中最為常見。 腫塊和丘疹癒合緩慢，當一個癒合時，另一個會彈出。 根據痤瘡的嚴重程度，它會在皮膚上留下疤痕並引起情緒困擾。 痤瘡藥物通過減少皮脂分泌、治療細菌感染和消腫來發揮作用。 健康皮膚的皮脂腺分泌的皮脂通過毛孔、毛囊的開口釋放到皮膚表面。 毛囊內襯有角質形成細胞，一種皮膚細胞。 當皮膚細胞脫落時，這些角質形成細胞通常會上升到皮膚表面。 毛髮、皮脂和角質形成細胞聚集在痤瘡患者的毛孔中。 結果，角質細胞不會脫落，皮脂也不會滲入皮膚表面。 炎症，如腫脹、發紅、發熱和疼痛，是由通常存在於皮膚中的細菌在被油脂和細胞堵塞的毛囊中繁殖引起的。

市場動態

產品等市場主要參與者越來越多地採用無機策略，預計這將在預測期內推動市場增長。 例如，製藥公司 Galderma 於 2022 年 3 月 25 日至 29 日在馬薩諸塞州波士頓舉行的美國皮膚病學會 (AAD) 年會上宣布，“TWYNEO（維甲酸和過氧化苯甲□）乳膏，0.1%/3%”將在美國上映。 TWYNEO 霜是第一個也是唯一一個含有 0□□.1% 維甲酸和 3% 過氧化苯甲□ (BPO) 的二合一配方，被證明對中度至重度面部痤瘡有效，並且已經過療效測試。

這項研究的主要特點

• 本報告對全球痤瘡藥物市場進行了深入分析，說明了以 2021 年為基準年的預測期（2022-2030 年）的市場規模和復合年增長率 (CAGR%) 的增長。
• 解釋了不同細分市場的潛在創收機會，並描述了針對該市場的有吸引力的投資建議矩陣。
• 它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
• 它根據以下參數介紹了全球痤瘡治療市場的主要參與者：公司亮點、產品組合、主要亮點、財務業績和戰略。
• 本研究涉及的主要公司包括 Galderma Laboratories, L.P、Reckitt Benckiser Group PLC.、Bausch Health Companies Inc.、GlaxoSmithKline plc.、Arctic Therapeutics International、Mylan N.V.、Sun Pharmaceutical Industries Ltd.、AbbVie Inc.、 Biopharmx, Inc.、Paratek Pharmaceuticals, Inc.、Teva Pharmaceutical Industries Ltd.、Johnson & Johnson、F. Hoffmann-La Roche Ltd
• 這份報告中的見解將使營銷人員和企業高管能夠就他們未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我認為我們可以。
• 《全球痤瘡治療藥物市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球痤瘡治療市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第2章市場展望

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 市場概況：按藥物類別
  • 市場概況：按類型分類
  • 市場概況：按指示
  • 按配方分類的市場概況
  • 市場概況：按銷售渠道
  • 市場概況：按地區
• 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

• 市場動態
  • 司機
  • 約束因素
  • 市場機會
• 影響分析
• 治療概述
  • 治療方法：按年齡
  • 按性別分類的療法
• 管道分析
• 監管場景
• 市場趨勢
• 最近的產品批准/發布
• 害蟲分析
• 主要發展狀況
• 流行病學
• 品牌分析

第 4 章全球痤瘡藥物市場-冠狀病毒 (COVID-19) 大流行的影響

• 經濟影響
• COVID-19 的流行病學特徵
• 對全球痤瘡治療藥物市場的總體影響

第 5 章全球痤瘡藥物市場：按藥物類別，2017-2030

• 維甲酸
• 外用維甲酸
• 口服維甲酸
• 抗生素
• 抗生素（外用
• 口服抗生素
• 組合
• 克林黴素 + 過氧化苯甲□
• 克林黴素 + 維甲酸
• 阿達帕林 + 過氧化苯甲□
• 維甲酸 + 過氧化苯甲□
• 其他
• 水楊酸
• 壬二酸
• 過氧化苯甲□
• 其他

第 6 章全球痤瘡治療市場類型，2017-2030

• 處方藥
• 場外交易

第 7 章。全球痤瘡藥物市場：按適應症分類，2017-2030

• 炎症性痤瘡
• 非炎症性痤瘡

第 8 章全球痤瘡藥物市場：按配方分類，2017-2030

• 外科學
• 口腔醫學

第 9 章。全球痤瘡藥物市場：按分銷渠道，2017-2030

• 醫院藥房
• 零售藥房
• 在線藥店

第 10 章全球痤瘡治療藥物市場，按地區劃分，2017-2030

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地區
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲地區
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 其他亞太地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中非
• 南非

第11章競爭格局

• Galderma Laboratories, L.P.
• Reckitt Benckiser Group PLC.
• Bausch Health Companies Inc.
• GlaxoSmithKline plc.
• Arctic Therapeutics International
• Mylan N.V.
• Sun Pharmaceutical Industries Ltd.
• AbbVie Inc.
• Biopharmx, Inc.
• Paratek Pharmaceuticals, Inc.
• Teva Pharmaceutical Industries Ltd
• Johnson & Johnson
• F. Hoffmann-La Roche Ltd

第12章章節

• 調查方法
• 關於出版商

Acne is a skin condition that occurs when your hair follicles become plugged with oil and dead skin cells. It results in pimples, blackheads, or whiteheads. Although, it can afflict anyone at any age, acne is most prevalent in teenagers. The lumps and pimples heal slowly, and just as one starts to go, another one seems to appear. Depending on how severe it is, acne can leave skin scars and create emotional distress. Acne treatments function by lowering sebum production, curing bacterial infections, and/or reducing swelling. Sebum produced by the sebaceous glands in healthy skin is released onto the skin's surface through the pore, a follicular opening. The follicle is lined with keratinocytes, a kind of skin cell. The keratinocytes normally ascend to the skin's surface during skin cell shedding. Hair, sebum, and keratinocytes clump together in the pore of an acne patient. As a result, the keratinocytes are kept from shedding and sebum is kept from penetrating the skin's surface. Inflammation, including swelling, redness, heat, and pain, is brought on by bacteria that ordinarily reside on the skin and can proliferate in clogged follicles when oil and cells are present.

Market Dynamics

Increasing adoption of inorganic strategies by key players in market such as product is expected to drive market growth over the forecast period. For instance, in March 2022, Galderma, a pharmaceutical company, announced the U.S. launch of TWYNEO (tretinoin and benzoyl peroxide) Cream, 0.1%/3%, during the American Academy of Dermatology (AAD) Annual Meeting, held during March 25-29, 2022, in Boston, Massachusetts. The first and only 0.1% tretinoin and 3% benzoyl peroxide (BPO) 2-in-1 formulation that has been shown to effectively treat moderate to severe face acne is TWYNEO Cream.

Key features of the study:

• This report provides an in-depth analysis of the global acne medication market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global acne medication market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Galderma Laboratories, L.P, Reckitt Benckiser Group PLC., Bausch Health Companies Inc., GlaxoSmithKline plc., Arctic Therapeutics International, Mylan N.V., Sun Pharmaceutical Industries Ltd., AbbVie Inc., Biopharmx, Inc., Paratek Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, F. Hoffmann-La Roche Ltd
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global acne medication market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acne medication market

Detailed Segmentation:

• Global Acne Medication Market, By Drug Class:
  • Topical Retinoid
  • Oral Retinoid
  • Topical Antibiotics
  • Oral Antibiotics
  • Clindamycin + Benzoyl Peroxide
  • Clindamycin + Tretinoin
  • Adapalene + Benzoyl Peroxide
  • Tretinoin + Benzoyl Peroxide
  • Others
  • Retinoid
  • Antibiotics
  • Fixed Dose Combinations
  • Salicylic Acid
  • Azelaic Acid
  • Benzoyl Peroxide
  • Others
• Global Acne Medication Market, By Type:
  • Prescription
  • OTC
• Global Acne Medication Market, By Indication:
  • Inflammatory Acne
  • Non-Inflammatory Acne
• Global Acne Medication Market, By Formulation:
  • Topical Medication
  • Oral Medication
• Global Acne Medication Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Acne Medication Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Galderma Laboratories, L.P.*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Reckitt Benckiser Group PLC.
  • Bausch Health Companies Inc.
  • GlaxoSmithKline plc.
  • Arctic Therapeutics International
  • Mylan N.V.
  • Sun Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Biopharmx, Inc.
  • Paratek Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Johnson & Johnson
  • F.Hoffmann-La Roche Ltd

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Type
  • Market Snapshot, By Indication
  • Market Snapshot, By Formulation
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Treatment Overview
  • Treatment By Age
  • Treatment By Gender
• Pipeline Analysis
• Regulatory Scenario
• Market Trends
• Recent Product Approval/Launch
• PEST Analysis
• Key Developments
• Epidemiology
• Brand Analysis

4. Global Acne Medication Market- Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Overall impact on Global Acne Medication Market

5. Global Acne Medication Market, By Drug Class, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Retinoid
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Topical Retinoid
• Oral Retinoid
• Antibiotics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Topical Antibiotics
• Oral Antibiotics
• Fixed Dose Combinations
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Clindamycin + Benzoyl Peroxide
• Clindamycin + Tretinoin
• Adapalene + Benzoyl Peroxide
• Tretinoin + Benzoyl Peroxide
• Others
• Salicylic Acid
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Azelaic Acid
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Benzoyl Peroxide
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Acne Medication Market, By Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Prescription
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• OTC
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Acne Medication Market, By Indication, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Inflammatory Acne
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Non-Inflammatory Acne
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Acne Medication Market, By Formulation, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Topical Medication
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Oral Medication
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Acne Medication Market, By Distribution Channel, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

10. Global Acne Medication Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

11. Competitive Landscape

• Galderma Laboratories, L.P.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Reckitt Benckiser Group PLC.
• Bausch Health Companies Inc.
• GlaxoSmithKline plc.
• Arctic Therapeutics International
• Mylan N.V.
• Sun Pharmaceutical Industries Ltd.
• AbbVie Inc.
• Biopharmx, Inc.
• Paratek Pharmaceuticals, Inc.
• Teva Pharmaceutical Industries Ltd
• Johnson & Johnson
• F. Hoffmann-La Roche Ltd

12. Section

• Research Methodology
• About Us